Asia / TAIWAN
Company Overview
Merdury Biopharmaceutical Corp. manufactures pharmaceutical products. It focuses on the development of drugs for unmet medical needs. It develop faster, lower side effects, and more in line with human needs for drugs. The company was founded on July 16, 2019 and is headquartered in New Taipei City. Taiwan.
Merdury Biopharmaceutical Corp. manufactures pharmaceutical products. It focuses on the development of drugs for unmet medical needs. It develop faster, lower side effects, and more in line with human needs for drugs. The company was founded on July 16, 2019 and is headquartered in New Taipei City. Taiwan.
Includes quarterly earnings and dividends.
Company Details
| Major Industry | Pharmaceuticals & Biotechnology |
| Sub Industry | Pharmaceutical Preparations |
| Country | TAIWAN |
| Employees | 19 |
| Reporting Unit | Billions |
| Primary Exchange | Unknown exchange |
| Instrument Type | Equity |
| Website | http://merdury.com |
| Wright ID | C158KQ033 |
Key Metrics
| Current price | $5.99 |
| Market cap | $2.56 B |
| P/E ratio | n/a |
| 52-week perf. | -15.5% |
| Common shares | 427.7 M |
| Share type | Gu |
| Quality rating | DCD0 |
| Dividend yield | 0.00% |
Recent stock performance
| 1 Week | +2.4% |
| 4 Week | -2.0% |
| 13 Week | +19.1% |
Officers
n/a
Address
No653 Bannan Road Zhonghe District
NEW TAIPEI
TAIWAN
235
| Phone | n/a |
Quarterly Earnings & Dividends
Try another report for annual statements, Wright Quality history or comparative analysis.